New York State Department of Health AIDS Institute (NYSDOH AI) - Division of HIV and Hepatitis Health Care - Bureau of Hepatitis Health Care, and Health Research, Inc. (HRI)
Grants to New York nonprofit health care organizations to increase access to treatment for people suffering from hepatitis C (HCV). Funding is intended for programs that provide access to treatment and care for people with HCV, increase the rate of successful HCV initiation and treatment, and increase the number of people who are cured of HCV. Special consideration will be given to populations that are underserved and socially disadvantaged.
The New York State Department of Health AIDS Institute (NYSDOH AI) Division of HIV and Hepatitis Health Care, Bureau of Hepatitis Health Care, and Health Research, Inc. (HRI) announce the availability funding in New York State (NYS) and federal funding for five (5) years to increase the number of people who are treated and cured for hepatitis C (HCV). As part of New York State’s (NYS’s) plan to eliminate HCV, this will be accomplished by creating a primary care-based integrated multidisciplinary model of care to serve all populations in an equitable manner, especially those currently underserved and socially disadvantaged. Funded applicants will conduct targeted outreach, linkage and care coordination to assist people with HCV, and HIV/HCV in accessing timely HCV medical care and appropriate supportive services in a primary care setting.
To impact the HCV epidemic and move towards elimination, models of care are needed to optimize the HCV care continuum by: outreaching to people who are most at risk and identifying those with HCV; proactively addressing the social and structural barriers that prevent them from engaging in care and prevention; facilitating health systems navigation and patient support; and creating convenient, accessible, multidisciplinary methods of HCV care and treatment delivery.
The goals of this RFA are to:
This will be accomplished by conducting targeted client outreach and recruitment and by providing care coordination, peer-delivered services, and HCV care and treatment utilizing a multidisciplinary care team approach in a primary care setting. Programs are expected to serve all people with HCV in an equitable manner, with attention to ensuring non-discriminatory care to those currently underserved and socially disadvantaged. The priority populations for this RFA are people with mono-infection of HCV and/or co-infection of HIV/HCV. This includes uninsured persons.
Successful applicants will demonstrate their ability to:
For information on program requirements, see page 9 of the RFP attached below.
GrantWatch ID#: 187075
Up to 15 awards
Annual awards will not exceed $300,000.
Funding will be awarded over a period of five years. It is expected that NYS contracts resulting from this RFA will have the following multi-year time period: July 1, 2020 – June 30, 2025.
HRI-funded contracts resulting from this RFA will be for 12-month terms. The anticipated start date of HRI contracts is July 1, 2020. However, depending on the funding source, the initial contract term could be for a shorter time period. HRI awards may be renewed for up to four (4) additional annual contract periods based on satisfactory performance and availability of funds.
Before starting your grant application, please review the funding source's website listed below for updates/changes/addendums/conferences/LOIs.
To apply: https://grantsgateway.ny.gov/IntelliGrants_NYSGG/login2.aspx
Colleen Flanigan, Director Bureau of Hepatitis Health Care
New York State Department of Health/AIDS Institute
USA: New York City; New York
Fundraising opportunity for USA, Canada, and International nonprofit organizations to host a jazz concert held in honor of their organization or cause. Applicants must contact the funding source prior to applying. In addition to funds raised through concert ticket sales
Grants to USA nonprofit organizations to reduce social inequality and promote solutions to the climate crisis. Eligible programs will address the areas of racial and economic justice, corporate and political accountability; voice, creativity, and culture; and an inclusi
Grants of up to $3,000 to USA and Canada nonprofit organizations for projects to protect wildlife and natural habitats. Funding is intended for campaigns to save specific species and ecosystems. Eligible activities include public policy work, litigation, advocacy, and d
Grants to USA and Canada individuals and families with low-income for financial assistance. Types of assistance include financial support to offset emergency expenses or to cover the cost of regular monthly bills. Funding is intended for workers and households that are
Grants to USA, Mexico, and Haiti nonprofits, for-profit organizations, and government entities for programs and services that improve the quality of life for underserved children. Focus areas include working families, equitable communities, and thriving children. The Fu
Donations to USA nonprofit organizations for programming support for arts, pre-K-12 education, and literacy programs across the country. In addition, sponsorship opportunities are provided to USA for-profit and nonprofit organizations focusing on literacy, the arts, a
Grants to New York, New Jersey, and Connecticut nonprofit organizations to benefit children in the New York City metropolitan area. Applicants must submit a Letter of Inquiry prior to applying. Consideration will be given to programs aimed at improving the emotional wel
Grants to USA nonprofits for activities that positively impact people around the world and their communities. Support is primarily given to programs in the areas of architecture and the arts, education, addressing the needs of underserved communities, and scientific res
Grants of up to $5,000 to New York nonprofit organizations and municipalities to protect, preserve, and interpret cultural and natural resources in eligible regions. Funding is intended as seed money to support marketing, promotion, programming, and interpretation proje
Award to a USA, Canada, or International scientist or team of scientists to recognize outstanding medical research accomplishments. Researchers eligible for nominations may be from any public or private organization or institution, including commercial or government ent